Medicine for migraines

As per available reports about 21 journals, 11 Conferences, 09 workshops are presently dedicated exclusively to medicine for migraines and about 1301 articles are being published on the current trends in medicine for migraines. In terms of research annually, USA, India, Japan, Brazil and Canada are some of the leading countries where maximum studies related to medicine for migraines are being carried out. Migraines are serious, potentially life-threatening neurological diseases which affects most of the people in which the majority is women. Migraines headache can cause intense throbbing or a pulsing sensation in one area of the head and is commonly accompanied by nausea, vomiting, and extreme sensitivity to light and sound. Migraines attacks can cause significant pain for hours to days and be so severe that all you can think about is finding a dark, quiet place to lie down. Medications can help reduce the frequency and severity of migraines.

The Journal of Brain Disorders & Therapy is an academic journal – hosted by OMICS International – a pioneer in open access publishing–and is listed among the top 10 journals in medicine for migraines. Each year research scientists have noticed a rise in the number of congresses being held in this field. The Journal of Brain Disorders & Therapy provides a unique platform to researchers and scientist to explore the advanced and latest research developments in the field of medicine for migraines thus bridging the gap between researchers and young scientists.

OMICS Group organizing 3rd International Conference and Exhibition on Neurology & Therapeutics with the theme “Novel Therapies in Neurosciences and Neurological Disorders” with a well reputed organizing committee during September 8-10, 2014, at Philadelphia, USA.